Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder

✍ Scribed by Philip Hazell; Shuyu Zhang; Tomasz Wolańczyk; Joanne Barton; Mats Johnson; Alessandro Zuddas; Marina Danckaerts; Andrula Ladikos; David Benn; Roni Yoran-Hegesh; Pal Zeiner; David Michelson

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 239 KB
• Volume: 15
• Category: Article
• ISSN: 1018-8827
• DOI: 10.1007/s00787-006-0506-y